Fibrin glue as a local drug-delivery system for bacteriophage PA5. 2019

Evgenii Rubalskii, and Stefan Ruemke, and Christina Salmoukas, and Andrey Aleshkin, and Svetlana Bochkareva, and Evgeny Modin, and Bakr Mashaqi, and Erin C Boyle, and Dietmar Boethig, and Maxim Rubalsky, and Eldar Zulkarneev, and Christian Kuehn, and Axel Haverich
Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany. rubalskii.evgenii@mh-hannover.de.

Fibrin glue has been used clinically for decades in a wide variety of surgical specialties and is now being investigated as a medium for local, prolonged drug delivery. Effective local delivery of antibacterial substances is important perioperatively in patients with implanted medical devices or postoperatively for deep wounds. However, prolonged local application of antibiotics is often not possible or simply inadequate. Biofilm formation and antibiotic resistance are also major obstacles to antibacterial therapy. In this paper we test the biocompatibility of bacteriophages incorporated within fibrin glue, track the release of bacteriophages from fibrin scaffolds, and measure the antibacterial activity of released bacteriophages. Fibrin glue polymerized in the presence of the PA5 bacteriophage released high titers of bacteriophages during 11 days of incubation in liquid medium. Released PA5 bacteriophages were effective in killing Pseudomonas aeruginosa PA01. Overall, our results show that fibrin glue can be used for sustained delivery of bacteriophages and this strategy holds promise for many antibacterial applications.

UI MeSH Term Description Entries
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001435 Bacteriophages Viruses whose hosts are bacterial cells. Phages,Bacteriophage,Phage
D015718 Fibrin Tissue Adhesive An autologous or commercial tissue adhesive containing FIBRINOGEN and THROMBIN. The commercial product is a two component system from human plasma that contains more than fibrinogen and thrombin. The first component contains highly concentrated fibrinogen, FACTOR VIII, fibronectin, and traces of other plasma proteins. The second component contains thrombin, calcium chloride, and antifibrinolytic agents such as APROTININ. Mixing of the two components promotes BLOOD CLOTTING and the formation and cross-linking of fibrin. The tissue adhesive is used for tissue sealing, HEMOSTASIS, and WOUND HEALING. Autologous Fibrin Tissue Adhesive,Fibrin Adhesive,Fibrin Glue,Fibrin Sealant System,Fibrinogen Adhesive,Beriplast,Crosseal,Fibrin Klebe System Immuno,Fibrin Seal,Fibrin Sealant,Fibrin Sealant, Human,Tisseel,Tissel,Tissucol,Transglutine,Adhesive, Fibrin,Adhesive, Fibrin Tissue,Adhesive, Fibrinogen,Glue, Fibrin,Human Fibrin Sealant,Seal, Fibrin,Sealant System, Fibrin,Sealant, Fibrin,Sealant, Human Fibrin,Tissue Adhesive, Fibrin
D016503 Drug Delivery Systems Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity. Drug Targeting,Delivery System, Drug,Delivery Systems, Drug,Drug Delivery System,Drug Targetings,System, Drug Delivery,Systems, Drug Delivery,Targeting, Drug,Targetings, Drug
D046529 Microscopy, Electron, Transmission Electron microscopy in which the ELECTRONS or their reaction products that pass down through the specimen are imaged below the plane of the specimen. Electron Diffraction Microscopy,Electron Microscopy, Transmission,Microscopy, Electron Diffraction,Transmission Electron Microscopy,Diffraction Microscopy, Electron,Microscopy, Transmission Electron

Related Publications

Evgenii Rubalskii, and Stefan Ruemke, and Christina Salmoukas, and Andrey Aleshkin, and Svetlana Bochkareva, and Evgeny Modin, and Bakr Mashaqi, and Erin C Boyle, and Dietmar Boethig, and Maxim Rubalsky, and Eldar Zulkarneev, and Christian Kuehn, and Axel Haverich
November 2010, Journal of controlled release : official journal of the Controlled Release Society,
Evgenii Rubalskii, and Stefan Ruemke, and Christina Salmoukas, and Andrey Aleshkin, and Svetlana Bochkareva, and Evgeny Modin, and Bakr Mashaqi, and Erin C Boyle, and Dietmar Boethig, and Maxim Rubalsky, and Eldar Zulkarneev, and Christian Kuehn, and Axel Haverich
March 2023, Photodiagnosis and photodynamic therapy,
Evgenii Rubalskii, and Stefan Ruemke, and Christina Salmoukas, and Andrey Aleshkin, and Svetlana Bochkareva, and Evgeny Modin, and Bakr Mashaqi, and Erin C Boyle, and Dietmar Boethig, and Maxim Rubalsky, and Eldar Zulkarneev, and Christian Kuehn, and Axel Haverich
March 2014, Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs,
Evgenii Rubalskii, and Stefan Ruemke, and Christina Salmoukas, and Andrey Aleshkin, and Svetlana Bochkareva, and Evgeny Modin, and Bakr Mashaqi, and Erin C Boyle, and Dietmar Boethig, and Maxim Rubalsky, and Eldar Zulkarneev, and Christian Kuehn, and Axel Haverich
July 2007, Journal of biomedical materials research. Part A,
Evgenii Rubalskii, and Stefan Ruemke, and Christina Salmoukas, and Andrey Aleshkin, and Svetlana Bochkareva, and Evgeny Modin, and Bakr Mashaqi, and Erin C Boyle, and Dietmar Boethig, and Maxim Rubalsky, and Eldar Zulkarneev, and Christian Kuehn, and Axel Haverich
March 2000, Biological & pharmaceutical bulletin,
Evgenii Rubalskii, and Stefan Ruemke, and Christina Salmoukas, and Andrey Aleshkin, and Svetlana Bochkareva, and Evgeny Modin, and Bakr Mashaqi, and Erin C Boyle, and Dietmar Boethig, and Maxim Rubalsky, and Eldar Zulkarneev, and Christian Kuehn, and Axel Haverich
September 2015, The spine journal : official journal of the North American Spine Society,
Evgenii Rubalskii, and Stefan Ruemke, and Christina Salmoukas, and Andrey Aleshkin, and Svetlana Bochkareva, and Evgeny Modin, and Bakr Mashaqi, and Erin C Boyle, and Dietmar Boethig, and Maxim Rubalsky, and Eldar Zulkarneev, and Christian Kuehn, and Axel Haverich
February 2008, Journal of the Chinese Medical Association : JCMA,
Evgenii Rubalskii, and Stefan Ruemke, and Christina Salmoukas, and Andrey Aleshkin, and Svetlana Bochkareva, and Evgeny Modin, and Bakr Mashaqi, and Erin C Boyle, and Dietmar Boethig, and Maxim Rubalsky, and Eldar Zulkarneev, and Christian Kuehn, and Axel Haverich
January 2018, Advances in experimental medicine and biology,
Evgenii Rubalskii, and Stefan Ruemke, and Christina Salmoukas, and Andrey Aleshkin, and Svetlana Bochkareva, and Evgeny Modin, and Bakr Mashaqi, and Erin C Boyle, and Dietmar Boethig, and Maxim Rubalsky, and Eldar Zulkarneev, and Christian Kuehn, and Axel Haverich
December 2017, Hospital practice (1995),
Evgenii Rubalskii, and Stefan Ruemke, and Christina Salmoukas, and Andrey Aleshkin, and Svetlana Bochkareva, and Evgeny Modin, and Bakr Mashaqi, and Erin C Boyle, and Dietmar Boethig, and Maxim Rubalsky, and Eldar Zulkarneev, and Christian Kuehn, and Axel Haverich
January 2022, Pharmaceutics,
Copied contents to your clipboard!